Biofrontera Inc. Files 8-K Report
Ticker: BFRIW · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1858685
Sentiment: neutral
Topics: corporate-disclosure, financial-reporting
Related Tickers: BFRI
TL;DR
Biofrontera Inc. filed an 8-K on June 3, 2025, updating on corporate events and financials.
AI Summary
On June 3, 2025, Biofrontera Inc. filed an 8-K report detailing other events and financial statements. The filing indicates the company's principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801. The report was filed under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing provides an update on Biofrontera Inc.'s corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- June 3, 2025 (date) — Date of earliest event reported
- 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801 (location) — Address of principal executive offices
- Securities Exchange Act of 1934 (legal_document) — Governing act for the filing
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of June 3, 2025.
What is the official name of the company filing this report?
The official name of the company filing this report is Biofrontera Inc.
Where are Biofrontera Inc.'s principal executive offices located?
Biofrontera Inc.'s principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 3, 2025.
Under which act is this current report filed?
This current report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Biofrontera Inc. (BFRIW).